Patents Assigned to 3E THERAPEUTICS CORPORATION
  • Compositions and methods for the treatment of a common cold and symptoms thereof
    Patent number: 9724317
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of a common cold, utilizing various methods of administration od X-ray contrast media (CM).
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: August 8, 2017
    Assignee: 3E Therapeutics Corporation
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • Compositions and methods for the treatment of inflammatory conditions
    Patent number: 9241919
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM).
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: January 26, 2016
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • X-ray contrast media compositions and methods of using the same
    Patent number: 9044448
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: June 2, 2015
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventor: Elliott C. Lasser
  • X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of CNS inflammation and inflammation associated conditions
    Patent number: 9044449
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: June 2, 2015
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventor: Elliott C. Lasser